When the endothelium cannot say 'NO' anymore -: ADMA, an endogenous inhibitor of NO synthase, promotes cardiovascular disease

被引:24
作者
Böger, RH [1 ]
机构
[1] Univ Hamburg Hosp, Ctr Med Expt, Clin Pharmacol Unit, Inst Expt & Clin Pharmacol, D-2000 Hamburg, Germany
关键词
D O I
10.1016/j.ehj.2003.08.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1901 / 1902
页数:2
相关论文
共 10 条
[1]   SERUM TOTAL HOMOCYSTEINE AND CORONARY HEART-DISEASE [J].
ARNESEN, E ;
REFSUM, H ;
BONAA, KH ;
UELAND, PM ;
FORDE, OH ;
NORDREHAUG, JE .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1995, 24 (04) :704-709
[2]   The L-arginine-nitric oxide pathway: Role in atherosclerosis and therapeutic implications [J].
Boger, RH ;
BodeBoger, SM ;
Frolich, JC .
ATHEROSCLEROSIS, 1996, 127 (01) :1-11
[3]  
BOGER RH, IN PRESS CARDIOVASC
[4]   Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention [J].
Lu, TM ;
Ding, YA ;
Lin, SJ ;
Lee, WS ;
Tai, HC .
EUROPEAN HEART JOURNAL, 2003, 24 (21) :1912-1919
[5]   Endogenous nitric oxide synthase inhibitor - A novel marker of atherosclerosis [J].
Miyazaki, H ;
Matsuoka, H ;
Cooke, JP ;
Usui, M ;
Ueda, S ;
Okuda, S ;
Imaizumi, T .
CIRCULATION, 1999, 99 (09) :1141-1146
[6]   Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men [J].
Ridker, PM ;
Cushman, M ;
Stampfer, MJ ;
Tracy, RP ;
Hennekens, CH .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (14) :973-979
[7]   A PROSPECTIVE-STUDY OF PLASMA HOMOCYST(E)INE AND RISK OF MYOCARDIAL-INFARCTION IN UNITED-STATES PHYSICIANS [J].
STAMPFER, MJ ;
MALINOW, MR ;
WILLETT, WC ;
NEWCOMER, LM ;
UPSON, B ;
ULLMANN, D ;
TISHLER, PV ;
HENNEKENS, CH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (07) :877-881
[8]   Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine [J].
Valkonen, VP ;
Päivä, H ;
Salonen, JT ;
Lakka, TA ;
Lehtimäki, T ;
Laakso, J ;
Laaksonen, R .
LANCET, 2001, 358 (9299) :2127-2128
[9]  
VALLANCE P, 1992, LANCET, V339, P572
[10]   Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease:: a prospective study [J].
Zoccali, C ;
Bode-Böger, SM ;
Mallamaci, F ;
Benedetto, FA ;
Tripepi, G ;
Malatino, LS ;
Cataliotti, A ;
Bellanuova, I ;
Fermo, I ;
Frölich, JC ;
Böger, RH .
LANCET, 2001, 358 (9299) :2113-2117